Kiwa Bio-Tech Announces Increased Sales and Income in its

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
45
Kiwa Bio-Tech Announces Increased Sales and Income in its Second Quarter

ONTARIO, CA--(Marketwired - Aug 15, 2017) - Kiwa Bio-Tech Products Group Corporation ( OTCQB : KWBT ) ("Kiwa" or the "Company"), a Company focused on eco-friendly biological fertilizers promoting harmless agriculture, released fiscal second quarter financial results that were driven by strong sales growth in Chinese market.

For the quarter ended June 30, 2017, the Company reported net income was $5,016,977 (including $4,513,363 one-time gain from discontinued operations), compared with $181,975 in the second quarter of 2016. 2017 second quarter revenue was $5,682,108, compared with $443,085 for the same period a year ago.

Key Highlights:

  • 2017 second quarter net income was $5,016,977 (including $4,513,363 one-time gain from discontinued operations), compared to net income of $181,975 in the second quarter of 2016.
  • 2017 second quarter net income from continuing operations increased 277% over 2016 second quarter net income from continuing operations.
  • 2017 second quarter revenue was $5,682,108, compared with $443,085 in the second quarter of 2016.
  • Our new biological organic fertilizer manufacturing base will commence operations at the end of 2017.
  • We expect to expand our 4 sales teams in various regions in China to increase market penetration and sales.

CEO Commentary

"We continue to see strong sales growth in our key markets on both a quarter-to-quarter and year-to-year basis. We believe that our growth derives from increasing demand for biological organic fertilizer products," said Kiwa CEO, Yvonne Wang. "To meet the need of this large and growing market, we expect that our new fertilizer manufacturing facility will commence operations by the end of 2017."

"During the second quarter of this fiscal year, the sales results exceeded our expectations and reached 25,500 tons of fertilizer products. This significant growth is due to the accomplishment of several milestones in our business plan. We plan to proactively adjust our product mix, expand our sales teams, and develop enhanced sales and marketing strategies in major agricultural areas of North, South and Central China. As a result, we believe that we can achieve our sales target of 100,000 tons of biological organic fertilizer products for the remainder of fiscal year 2017. At the same time, Kiwa is participating in establishing the standard system of harmless agriculture, which will have a significant impact on the development of agriculture in China," said Wang.

Market Outlook

  • In China, the biological organic fertilizer markets continue to grow due to increasing demand and strong consumption in most key economic crop planting regions in China. The tea-planting region in South and Central parts of China covers an area of approximately 3,320,000 mu (221,333 hectares) and the tobacco and orange planting areas in South China cover approximate 770,000 mu (51,333 hectares) and 2,557,498 mu (170,500 hectares) respectively.
  • The Chinese Ministry of Agriculture issued a notice "Implementation of the Plan to Use Organic Fertilizer on the Cultivation of Fruit, Vegetables and Tea" in April 2017. The notice created a requirement to use at least 50 % organic fertilizer in China's main planting areas of fruit, vegetables and tea by 2020 as a part of a program to replace chemical fertilizer with biological organic fertilizer.

About Kiwa Bio-Tech Products Group Corporation

Leader in Harmless Agricultural Industry Chain

Kiwa Bio-Tech Products Group Corporation develops, manufactures, distributes, and markets innovative, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes.

Kiwa is dedicated to eco-agricultural development and environmental control by developing, producing, and selling bio-technological products with high technology, low-cost, and high productivity to satisfy the growing market demand. Kiwa's development is creating a standardized and ecologically safe agricultural industry chain platform. The Company's development effort is based in China, and has gradually expanded to the international market.

Kiwa uses new bio-technological skills at its core, with organic, ecologically sound, and "green" practices as its theme. The Company strives for customer satisfaction and continued development. Kiwa is dedicated to making safe food, further developing eco-agriculture and upholding a responsibility of contributing to China's agricultural safety, food safety, and a healthy lifestyle. For more information on Kiwa and its products, please refer to the Company's website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission, available for free at www.sec.gov .

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

CONTACT INFORMATION Kiwa Bio-Tech Products Group Corporation Molly Han molly@kiwabiotech.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 6

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 3

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 3

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 4

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading

Top 5 Most Recently Viewed Articles

Impact of Rising Medical Costs on Major Insurers Post-COVID

Updated Category News Views 97

Understanding the Financial Struggles of Major Insurers In the aftermath of the COVID-19 pandemic, several large insurers have been grappling with inflation in medical expenses, especially within their government-sponsored Medicaid programs. The cessation of pandemic-era policies has unveiled challenges that were once masked by continuous enrollment provisions and...

Continue Reading
VMX 2026: A Revolutionary Event for Animal Health Professionals

Updated Category News Views 108

VMX 2026: A Hub of Veterinary Innovation As the Orange County Convention Center fills with nearly 30,000 veterinary professionals, VMX 2026 stands out as the pivotal global veterinary conference. Over 85 countries are represented, creating an atmosphere buzzing with energy, ideas, and innovations. This annual gathering focuses on advancing veterinary care, reinforcing the...

Continue Reading
Innovative Partnership Enhances Maternal Health Support Services

Updated Category News Views 87

Pacify's New Collaboration with First Choice Pacify, a distinguished provider of maternity care solutions, is embarking on an exciting collaboration with First Choice by Select Health, a prominent Medicaid managed care plan in its state. This partnership aims to introduce technology-driven, doula-assisted maternal health services aimed at First Choice's qualifying...

Continue Reading
Vin Farrell Joins Omnicom Production as Head of Studio

Updated Category News Views 255

Omnicom Production Welcomes New Head of Studio Omnicom Production is excited to announce the appointment of Vin Farrell as its new Head of Studio. With a wealth of experience, Farrell is set to make a significant impact in this innovative role. Vin Farrell's Impressive Background Farrell brings three decades of production experience, paving the path for new methodologies...

Continue Reading
Top AI Stocks for Future Investment Potential

Updated Category News Views 180

Predictions for the Largest AI Stocks by 2035 As we look ahead to the evolving landscape of artificial intelligence (AI), it's important to identify which companies are likely to become market leaders. Reflecting on the significant advancements made since 2013, we can see how they have laid the groundwork for a promising future. In this article, we will examine three key...

Continue Reading